Found: 16
Select item for more details and to access through your institution.
Efficacy of Lamivudine Plus Dolutegravir vs Dolutegravir-Based 3-Drug Regimens in People With HIV Who Are Virologically Suppressed.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 5, p. 1, doi. 10.1093/ofid/ofae198
- By:
- Publication type:
- Article
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients During Lamivudine Plus Dolutegravir Maintenance Therapy in Clinical Practice.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 7, p. 1, doi. 10.1093/ofid/ofab103
- By:
- Publication type:
- Article
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV.
- Published in:
- Journal of NeuroVirology, 2022, v. 28, n. 3, p. 422, doi. 10.1007/s13365-022-01078-z
- By:
- Publication type:
- Article
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition.
- Published in:
- Journal of NeuroVirology, 2020, v. 26, n. 6, p. 899, doi. 10.1007/s13365-020-00891-8
- By:
- Publication type:
- Article
Are we ready for long‐acting? A feasibility evaluation of long‐acting cabotegravir–rilpivirine in clinical practice.
- Published in:
- Journal of Medical Virology, 2022, v. 94, n. 10, p. 4970, doi. 10.1002/jmv.27890
- By:
- Publication type:
- Article
Home Care Assistance: Has Covid-19 had an Impact on the Complex Management of HIV Patients?
- Published in:
- AIDS & Behavior, 2023, v. 27, n. 4, p. 1173, doi. 10.1007/s10461-022-03854-8
- By:
- Publication type:
- Article
A 67-Year-Old Man with Chronic Lymphocytic Leukemia (CLL) on Maintenance Therapy with Ibrutinib with Persistent SARS-CoV-2 Infection Unresponsive to Antiviral Treatments.
- Published in:
- 2024
- By:
- Publication type:
- Case Study
Changes in Metabolic Profile in PLWHIV Switching to Doravirine-Based Regimen.
- Published in:
- Viruses (1999-4915), 2023, v. 15, n. 5, p. 1046, doi. 10.3390/v15051046
- By:
- Publication type:
- Article
Efficacy and durability of two‐ vs. three‐drug integrase inhibitor‐based regimens in virologically suppressed HIV‐infected patients: Data from real‐life ODOACRE cohort.
- Published in:
- HIV Medicine, 2021, v. 22, n. 9, p. 843, doi. 10.1111/hiv.13146
- By:
- Publication type:
- Article
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID‐19) pandemic.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
EFFICACY OF 3TC+DTG VS 3-DRUG REGIMENS IN VIROLOGICALLYSUPPRESSED PLWH.
- Published in:
- Topics in Antiviral Medicine, 2023, v. 31, n. 2, p. 227
- By:
- Publication type:
- Article
The association between stigma and wellbeing in an Italian cohort of PLWH: The role of social support and personal factors.
- Published in:
- International Journal of STD & AIDS, 2024, v. 35, n. 3, p. 176, doi. 10.1177/09564624231213115
- By:
- Publication type:
- Article
Toxoplasmosis mimicking CMV chorioretinitis in newly diagnosed PLWH: a case report.
- Published in:
- Infezioni in Medicina, 2023, v. 31, n. 3, p. 404, doi. 10.53854/liim-3103-15
- By:
- Publication type:
- Article
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice.
- Published in:
- Infezioni in Medicina, 2018, v. 26, n. 4, p. 336
- By:
- Publication type:
- Article
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice.
- Published in:
- 2019
- By:
- Publication type:
- Letter